Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
O. Yakovleva, A. Klekot, A. Lifanov (Vinnitsa, Ukraine). The nitroxidergic system state at systemic lupus erythematosus-associated pulmonary hypertension. Eur Respir J 2010; 36: Suppl. 54, 1082

Member's Comments

No comment yet.

Related content which might interest you: Endothelium dysfunction in systemic lupus erythematosus patients with pulmonary hypertension Source: Annual Congress 2011 - Clinical features of pulmonary hypertension Year: 2011 Pulmonary arterial hypertension and systemic lupus erythematosus Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Immunosuppression in systemic lupus erythematosus associated pulmonary arterial hypertension (SLE-APAH): Improvement in exercise and functional capacity Source: Annual Congress 2011 - Treatment of pulmonary hypertension Year: 2011 Pulmonary hypertension in systemic sclerosis and systemic lupus erythematosus Source: Eur Respir Rev 2011; 20: 277-286 Year: 2011 Effectiveness of ²Korargin² in the therapy of pulmonary arterial hypertension in patients with systemic lupus erythematosus Source: Annual Congress 2011 - Treatment of pulmonary hypertension Year: 2011 Pulmonary involvement in systemic lupus erythematosus, Sjögren syndrome and mixed connective tissue disease Source: Eur Respir Monogr 2019; 86: 106-123 Year: 2019 Long-term prognosis of patients with systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study Source: Eur Respir J, 53 (2) 1800081; 10.1183/13993003.00081-2018 Year: 2019 Pulmonary hypertension in systemic scleroderma Source: Eur Respir J 2003; 22: Suppl. 45, 269s Year: 2003 Early outcomes of patients with systemic lupus erythematosus and antiphospholipid syndrome after pulmonary endarterectomy Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension Year: 2016 Examining pulmonary function measures in patients with systemic lupus erythematosus (SLE) Source: Virtual Congress 2020 – Rare lung diseases and lung manifestations of extrapulmonary diseases Year: 2020 Raynaud phenomenon is correlated with systolic pulmonary arterial pressure in patients with systemic lupus erythematosus Source: Eur Respir J 2006; 28: Suppl. 50, 827s Year: 2006 A functionally improved case of obstructive impairment caused by systemic lupus erythematosus Source: Breathe, 17 (2) 200288; 10.1183/20734735.0288-2020 Year: 2021 The profile of lung scintigraphy in systemic lupus erythematosus with chronic pulmonary embolism:a cross-section Source: Virtual Congress 2020 – Epidemiology, diagnosis and management of pulmonary embolism Year: 2020 Pulmonary arterial hypertension in scleroderma – manifestation of systemic endothelial dysfunction Source: Eur Respir J 2006; 28: Suppl. 50, 548s Year: 2006 Secondary pulmonary hypertension in chronic obstructive pulmonary disease and systemic lupus erythematosus- pathophysiology and treatment Source: Eur Respir J 2004; 24: Suppl. 48, 59s Year: 2004 Management and prognosis of respiratory manifestations revealing systemic lupus erythematosus Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases Year: 2007 Systemic autoimmunity and  pulmonary fibrosis Source: International Congress 2017 – GR3 Scientific Grand Round: Autoimmunity in chronic lung disease Year: 2017 Pulmonary arterial hypertension in systemic sclerosis: a distinctive endotheliopathy? Source: Eur Respir J 2010; 35: 223-224 Year: 2010 Systemic lupus erythematosus (SLE): Cyto- and chemokines as possible serum markers for pulmonary involvement? Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease Year: 2012 Lung abnormalities in patients with systemic lupus erythematosus Source: Eur Respir J 2001; 18: Suppl. 33, 225s Year: 2001